Barriers and facilitators to conduct high-quality, large-scale safety and comparative effectiveness research: The Biologics and Biosimilars Collective Intelligence Consortium experience
Pharmacoepidemiol Drug Saf. 2020 Jul;29(7):811-813.
doi: 10.1002/pds.4885.
Epub 2019 Aug 11.